RPG Life Sciences Ltd
As of 20 Nov 2026, RPG Life Sciences is in Stage 2, the uptrend phase, now in week 21 (since 23 Jun 2026). It closed at ₹2,541, 17.7% below its 52-week high and above its 200-day average, which is rising. In Health Care, 34.7% of stocks are in Stage 2.
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. More about the company
Pro read
ProRPGLIFE is about 5 months into its Stage 2 advance, 8% below its 50-day average and 18% under its 52-week high. A pause below the 50-day inside an uptrend is the weakest spot of the move until it closes back above the line.
Its relative strength is 73 of 99, above the middle among NSE stocks over the past year. Pharmaceuticals ranks 7 of 106 industries by the strength of its stocks, among the leaders.
Stocks with a similar setup at this point in their move ran 0.6 points behind the average stock over the next 30 sessions on average, after costs, and their typical best close within 60 sessions was 14% above entry.
The trend read holds while it stays in Stage 2. A close below ₹2,763, its 50-day average, would put it at rest; ₹2,471, 20% under its 52-week high of ₹3,089, is where a trailing stop would sit.
Setup-score rank among Stage 2 peers: #31 of 50 in Pharmaceuticals · #40 of 61 in Health Care
Is RPGLIFE early, or has it already run? Pro answers that for every NSE stock, after every close.
RPGLIFE among Pharmaceuticals57th of 118 by relative strength
All 118 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | BLISSGVS | Stage 2 · wk 49 | 99 | +4.6% |
| 2 | KPL | Stage 2 · wk 44 | 99 | +20.5% |
| 3 | FREDUN | Stage 2 · wk 33 | 98 | +24.0% |
| 4 | VENUSREM | Stage 3 · wk 10 | 98 | −1.5% |
| 5 | RUBICON | Stage 3 · wk 4 | 98 | +18.7% |
| 6 | SAKAR | Stage 2 · wk 55 | 98 | +13.1% |
| 7 | BAFNAPH | Stage 2 · wk 23 | 98 | +1.9% |
| 8 | INDSWFTLAB | Stage 2 · wk 23 | 98 | −7.4% |
| …57 | RPGLIFE | Stage 2 · wk 21 | 73 | −9.2% |
Mutual fund holdings
Held by 4 mutual funds in portfolios to October 2026: 0 active funds and 4 index funds and ETFs.
In October, no active fund changed its holding.
All 4 funds and what each did in October
Mutual funds holding RPGLIFE: the ten largest and the month’s moves →
RPG Life Sciences: quick answers
What stage is RPG Life Sciences in?
As of 20 Nov 2026, RPG Life Sciences (RPGLIFE) is in Stage 2, the uptrend phase. It entered Stage 2 on 23 Jun 2026 and is in week 21. What the four stages mean
Is RPG Life Sciences in an uptrend?
Yes. RPG Life Sciences is in a Stage 2 uptrend. It trades 5.9% above its 200-day average, which is rising.
How far is RPG Life Sciences from its 52-week high?
RPG Life Sciences closed at ₹2,541 on 20 Nov 2026, 17.7% below its 52-week high of ₹3,089. Its 52-week low is ₹1,744.
How has RPG Life Sciences performed over the past year?
As of 20 Nov 2026, RPG Life Sciences is up 8.9% over the past year and up 9.4% so far in 2026.
Which sector and industry is RPG Life Sciences in?
RPG Life Sciences is in the Pharmaceuticals industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Pharmaceuticals
About this companyHealth Care· Pharmaceuticals
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Visit company website →All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.